For BMT Healthcare Professionals

BSBMTCT Vaccination Sub Committee – Latest statement

BSBMTCT SARS-CoV-2 vaccination statement_01Aug2023

Anthony Nolan Cost of Living Research

Management of patients with Germline predisposition to haematological Malignancies Guidelines

Br J Haematol – 2023 – Clark – Management of patients with germline predisposition to haematological malignancies

JOINT Guidelines with BSBMTCT

Joint Consensus Statement on the Vaccination of Adult and Paediatric Haematopoietic Stem Cell Transplant Recipients. Prepared on Behalf of the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT), the Children’s Cancer and Leukaemia Group (CCLG), and British Infection Association (BIA) (14th November 2022)

NHSE related Guidance/Guidelines

BSBMTCT reply to NHSE regardiing a new CART tariff_signed_OE_JS_SG_04012023

Allogeneic haematopoietic stem cell transplantation for adults with sickle cell disease (NHSE)

CRG/NHS England Letter Treatment of severe RSV HPIV post HSCT

Notification to BMT Directors – CRG/BSBMT/NHS England

Urgent Policy Statement regarding BMT of adult patients with primary immune deficiencies

BSBMTCT Documents

BSBMTCT Meeting Grants Handbook v 1_2023

BSBMTCT_meeting_grant_application_form v 1_2023

2017 BSBMT 8th Report To Specialist Commissioners

Other related documents/guidance

Safe Transfusions in Haemopoietic Stem Cell Transplant recipients (updated August 2021) Please direct queries to

2nd Annual Immunomodulation Report

FRCPath Haematology Exams Help Website

EBMT Transplant book for nurses

Stem Cell Evidence– new open access collection of high quality research relevant to HSCT (Flyer)

EBMT HCT Curriculum

PHGF Personalised Medicine Technology Landscape Report 050918


Latest newsletter: January 2022

Select newsletter to download